The city of Amarillo, Texas, currently has 1 active clinical trials seeking participants for Rheumatoid Arthritis research studies.
A Study of Baricitinib in Participants With Rheumatoid Arthritis
Recruiting
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: Amarillo Center for Clinical Research, Amarillo, Texas
Conditions: Rheumatoid Arthritis